Tampa General Hospital Gynecologic Oncology

Topics

• Ovarian cancer diagnosis and treatment 48
• Endometrial and Cervical Cancer Treatments 46
• HER2/EGFR in Cancer Research 19
• Uterine Myomas and Treatments 19
• Cervical Cancer and HPV Research 12
• Intraperitoneal and Appendiceal Malignancies 10
• PARP inhibition in cancer therapy 9
• MicroRNA in disease regulation 8
• Cancer Cells and Metastasis 7
• Cell death mechanisms and regulation 5
• Immunotherapy and Immune Responses 5
• Maternal and fetal healthcare 5

Most cited

1. NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 127 citations · Sharon Robertson

2. Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 111 citations · Vaagn Andikyan

3. Self-Collection for Cervical Cancer Screening in a Safety-Net Setting: The PRESTIS Randomized Clinical Trial.

   JAMA internal medicine · 2025 · 19 citations · Matthew Anderson

4. Integrated mutational landscape analysis of uterine leiomyosarcomas.

   Proceedings of the National Academy of Sciences of the United States of America · 2021 · 105 citations · Vaagn Andikyan

5. Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278).

   Gynecologic oncology · 2025 · 17 citations · Sharon Robertson

6. PARP Inhibitors in Ovarian Cancer: Resistance Mechanisms, Clinical Evidence, and Evolving Strategies.

   Biomedicines · 2025 · 19 citations ·